0001193125-21-288350 Sample Contracts

LEASE by and between B9 LS HARRISON & WASHINGTON LLC, a Delaware limited liability company and PYXIS ONCOLOGY, INC., a Delaware corporation

Lease • October 1st, 2021 • Pyxis Oncology, Inc. • Pharmaceutical preparations

• Contract Type
  Lease
• Filed
  October 1st, 2021
• Company
  Pyxis Oncology, Inc.
• Industry
  Pharmaceutical preparations

THIS LEASE (this “Lease”) is entered into as of this 29th day of September, 2021 (the “Execution Date”), by and between B9 LS HARRISON & WASHINGTON LLC, a Delaware limited liability company (“Landlord”), and PYXIS ONCOLOGY, INC., a Delaware corporation (“Tenant”).

AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT

Investors’ Rights Agreement • October 1st, 2021 • Pyxis Oncology, Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  Investors’ Rights Agreement
• Filed
  October 1st, 2021
• Company
  Pyxis Oncology, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 5th day of March, 2021, by and among Pyxis Oncology, Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”.

Confidential

Consideration Agreement • October 1st, 2021 • Pyxis Oncology, Inc. • Pharmaceutical preparations

• Contract Type
  Consideration Agreement
• Filed
  October 1st, 2021
• Company
  Pyxis Oncology, Inc.
• Industry
  Pharmaceutical preparations

THIS AMENDMENT TO OPT-IN, INVESTMENT AND ADDITIONAL CONSIDERATION AGREEMENT (the “Amendment”) is made as of August 2, 2021, to be effective as of January 1, 2021 (“Effective Date”) as part of the License between the Parties (each as defined below).

CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. AMENDED AND RESTATED COLLABORATION AGREEMENT by and among...

Collaboration Agreement • October 1st, 2021 • Pyxis Oncology, Inc. • Pharmaceutical preparations • New York

• Contract Type
  Collaboration Agreement
• Filed
  October 1st, 2021
• Company
  Pyxis Oncology, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

This AMENDED AND RESTATED COLLABORATION AGREEMENT (this “Agreement”) is entered into as of September 28, 2021, to be effective as of March 30, 2021 (the “Effective Date”), by and among Pyxis Oncology, Inc., a Delaware corporation, having offices at 35 CambridgePark Drive, Cambridge, MA 02140 (“Pyxis”), Alloy Therapeutics, Inc., a Delaware corporation, having offices at 44 Hartwell Avenue, Suite 2, Lexington, MA 02421 (“Alloy”), and Voxall Therapeutics, LLC, a Delaware limited liability company, having offices at 44 Hartwell Avenue, Suite 2, Lexington, MA 02421 (the “Company”). Pyxis, Alloy and the Company are each referred to herein by name or as a “Party” or, collectively, as the “Parties.”